Fuat
0000-0002-0439-2502
3 papers found
Refreshing results…
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
The mammalian target of rapamycin protein expression in human granulosa cell tumors
YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer
Missing publications? Search for publications with a matching author name.